Raymond James & Associates Atrion Corp Transaction History
Raymond James & Associates
- $150 Billion
- Q2 2024
A detailed history of Raymond James & Associates transactions in Atrion Corp stock. As of the latest transaction made, Raymond James & Associates holds 7,072 shares of ATRI stock, worth $3.23 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,072
Previous 7,123
0.72%
Holding current value
$3.23 Million
Previous $3.3 Million
3.09%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding ATRI
# of Institutions
115Shares Held
1.24MCall Options Held
0Put Options Held
0-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA203KShares$92.9 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY179KShares$81.8 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD139KShares$63.4 Million0.04% of portfolio
-
Black Rock Inc. New York, NY104KShares$47.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA84.9KShares$38.8 Million0.0% of portfolio
About ATRION CORP
- Ticker ATRI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 1,785,990
- Market Cap $816M
- Description
- Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...